Meeting Coverage:

Aspen Retinal Detachment Society

ARDS: 2021

An Update on Surgical Approaches to Gene and Cell Therapies

Show Description +

Allen Ho, MD, discusses the latest advances in gene and cell therapies, and how novel surgical approaches may change the way we treat patients in the near future.

Posted: 2/23/2021

Up Next

ROP in the Era of Anti-VEGF

R.V. Paul Chan, MD, MSc, MBA, FACS, Timothy G. Murray, MD, MBA


Advancements in Retinal Detachment Repair

Maria H. Berrocal, MD, Timothy G. Murray, MD, MBA

The Promise of Macular Reconstruction

Timothy W. Olsen, MD, Timothy G. Murray, MD, MBA

An Update on Brolucizumab One Year Later

Ryan Rich, MD; Timothy G. Murray, MD

Diabetic Retinopathy: Treat Them Early

Maria H. Berrocal, MD; Timothy G. Murray, MD

Track the History–and Future–of Anti-VEGF

Robert Avery, MD; Timothy G. Murray, MD

ARDS Stays In-Person, Safely

Timothy G. Murray, MD, MBA

An Update on Surgical Approaches to Gene and Cell Therapies

Allen Ho, MD, discusses the latest advances in gene and cell therapies, and how novel surgical approaches may change the way we treat patients in the near future.

Posted: 2/23/2021


Please log in to leave a comment.

More From ARDS: 2021 Coverage

An Update on Brolucizumab One Year Later

Ryan Rich, MD; Timothy G. Murray, MD

Diabetic Retinopathy: Treat Them Early

Maria H. Berrocal, MD; Timothy G. Murray, MD

Track the History–and Future–of Anti-VEGF

Robert Avery, MD; Timothy G. Murray, MD